Generic and biosimilar pricing tiers as a % of the originator drug price

Zawia3 · Chart 3 of 7

From 80% for the first biosimilar down to 50% for the sixth generic or more

“70% for the first generic, 65% for the second and third, 60% for the fourth and fifth, 50% from the sixth onward; biosimilars at 80%, 75%, 70%, and 60% in the same order.”

Any price increase on the originator drug automatically passes through to all its generics and biosimilars at rates between 50% and 80% of its price.

Source: Egyptian Drug Authority Decision No. 480 of 2026 — Article 4